Actively Recruiting

Phase Not Applicable
Age: 18Years - 70Years
FEMALE
NCT06080620

The Choice of Treatment Methods and Efficacy of LABC

Led by Peking Union Medical College Hospital · Updated on 2023-10-12

50

Participants Needed

1

Research Sites

146 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this clinical trial is to compare the therapeutic effects of chemotherapy followed by surgery and surgery followed by chemotherapy in patients with locally advanced breast cancer(LABC). Patients with LABC will be randomly divided into two groups, each receiving chemotherapy followed by surgery or surgery followed by chemotherapy. The main comparison was between the disease-free survival (DFS) of two groups of patients, with the secondary study endpoint being overall survival (OS); Five year survival; Local recurrence or distant metastasis rate.

CONDITIONS

Official Title

The Choice of Treatment Methods and Efficacy of LABC

Who Can Participate

Age: 18Years - 70Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Female aged 18 to 70 years
  • Diagnosed with locally advanced breast cancer (stage IIIb to IIIc)
  • Clinical or biopsy-confirmed breast cancer
  • Tumor evaluated as potentially removable by surgery (ultrasound shows tumor not surrounding axillary vein)
  • Accept treatment plans including surgery, radiotherapy, and chemotherapy
  • Volunteer to participate and sign informed consent
  • Willing to complete follow-up and quality of life and psychological assessments
Not Eligible

You will not qualify if you...

  • Younger than 18 or older than 70 years
  • Previous breast cancer surgery, radiotherapy, or chemotherapy
  • Not expected to undergo surgery, radiotherapy, or chemotherapy
  • History of other malignant tumors
  • Pregnant or breastfeeding
  • Active infection or fever
  • Serious diseases affecting trial compliance such as severe heart or lung problems, liver or kidney dysfunction, uncontrolled diabetes, or mental illness

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Ying Xu

Beijing, China, 100730

Actively Recruiting

Loading map...

Research Team

Y

Ying Xu

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

FACTORIAL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here